View the Latest: Medicare Part D
Filter
-
-
-
Policy Workshop on Formularies and Medicare
Event Date:EventThe Kaiser Family Foundation hosted a March 14, 2005 policy workshop on the use of drug formularies in the private sector and their potential implications for beneficiaries under the new Medicare drug benefit, set to go into effect January 1, 2006.
-
Medicare Prescription Drugs and Low-Income Beneficiaries – Presentation
EventSummary of Low-Income Subsidy Program in Final Medicare Bill This presentation summarizes the dual eligible population, the low-income provisions of the new Medicare drug benefit and discusses the impact on state Medicaid programs. Presentation Slides (.
-
The Role of Health Coverage for People with Disabilities
Event Date:EventPeople with disabilities are at risk in the health-care system because of their wide-ranging health-care needs, their relatively heavy use of prescription drugs, health-care and support services, and typically low incomes. A new survey of people with permanent mental and/or physical disabilities explores their health-care experiences and challenges in accessing and paying for care.
-
Improving Prescription Drug Coverage: Opportunities and Challenges for Reform
Event Date:EventTricia Neuman, Vice President and Director of the Medicare Policy Project, testified before the Senate Finance Committee on prescription drug coverage under Medicare. The statement reviews existing sources of prescription drug coverage for Medicare beneficiaries and the importance of such coverage for this population.
-
The Part D Experience: What are the Lessons for Broader Medicare Reform?
Event Date:EventLaunched in 2006, Medicare added a prescription drug benefit that relies entirely on private plans, while, for other benefits, beneficiaries have a choice between private health plans and traditional fee-for-service Medicare.
-
The State of Retiree Health Benefits: Historical Trends and Future Uncertainties
EventTricia Neuman, Vice President and Director of the Medicare Policy Project for the Kaiser Family Foundation, testified on Monday, May 17, at a
-
A Current Snapshot of the Medicare Part D Prescription Drug Benefit
Issue BriefThis brief provides an overview of the Medicare Part D prescription drug benefit, including current data on plan availability, enrollment, and spending and financing, and highlights changes made under the Inflation Reduction Act.
-
Medicare Part D Premiums Are Increasing for Many But Not All Stand-Alone Plans in 2025, Reflecting Effects of New Premium Stabilization Demonstration
Policy WatchThis policy watch examines monthly premiums for Medicare Part D stand-alone drug plans in 2025, as changes to the Part D benefit are being implemented in 2025, including a new $2,000 cap on out-of-pocket drug spending.